David O. Watson Apellis Pharmaceuticals, Inc. (APLS) insider trading activity

David O. Watson is General Counsel of Apellis Pharmaceuticals, Inc.. Currently has a direct ownership of 144,299 shares of APLS, which is worth approximately $4.25 Million. The most recent transaction as insider was on Apr 25, 2022, when has been sold 5,000 shares (Common Stock) at a price of $50.0 per share, resulting in proceeds of $250,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 144K

22.58% 3M change

38.52% 12M change

Total Value Held $4.25 Million

David O. Watson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 25 2022	SELL Open market or private sale	$250,000 $50.0 p/Share	5,000 Reduced 3.83%	125,569 Common Stock
Apr 21 2022	SELL Other acquisition or disposition	-	1,875 Reduced 1.42%	130,569 Common Stock
Feb 10 2022	SELL Payment of exercise price or tax liability	$23,136 $47.12 p/Share	491 Reduced 0.37%	132,444 Common Stock
Jan 28 2022	SELL Payment of exercise price or tax liability	$25,084 $38.59 p/Share	650 Reduced 0.49%	132,935 Common Stock
Jan 21 2022	BUY Grant, award, or other acquisition	-	26,051 Added 16.32%	133,585 Common Stock
Dec 27 2021	SELL Open market or private sale	$58,200 $48.5 p/Share	1,200 Reduced 1.1%	107,534 Common Stock
Dec 22 2021	SELL Open market or private sale	$507,937 $48.05 p/Share	10,571 Reduced 8.86%	108,734 Common Stock
Dec 22 2021	BUY Exercise of conversion of derivative security	$289,613 $14.4 p/Share	20,112 Added 14.98%	114,131 Common Stock
Sep 10 2021	BUY Exercise of conversion of derivative security	$4,112 $4.31 p/Share	954 Added 0.95%	99,193 Common Stock
Jun 21 2021	BUY Exercise of conversion of derivative security	$2,108 $4.31 p/Share	489 Added 0.5%	98,239 Common Stock
May 28 2021	BUY Exercise of conversion of derivative security	$2,108 $4.31 p/Share	489 Added 0.5%	97,750 Common Stock
Apr 22 2021	BUY Exercise of conversion of derivative security	$2,108 $4.31 p/Share	489 Added 0.5%	97,261 Common Stock
Mar 22 2021	BUY Exercise of conversion of derivative security	$4,215 $4.31 p/Share	978 Added 1.0%	96,772 Common Stock
Feb 10 2021	SELL Payment of exercise price or tax liability	$22,333 $47.72 p/Share	468 Reduced 0.49%	95,794 Common Stock
Jan 28 2021	BUY Grant, award, or other acquisition	-	9,375 Added 8.87%	96,262 Common Stock
Jan 27 2021	BUY Exercise of conversion of derivative security	$175,671 $4.04 p/Share	43,483 Added 33.35%	86,887 Common Stock
Dec 14 2020	SELL Open market or private sale	$447,110 $53.24 p/Share	8,398 Reduced 16.21%	43,404 Common Stock
Dec 14 2020	BUY Exercise of conversion of derivative security	$116,312 $13.85 p/Share	8,398 Added 13.95%	51,802 Common Stock
Dec 11 2020	SELL Open market or private sale	$496,750 $50.0 p/Share	9,935 Reduced 18.63%	43,404 Common Stock
Dec 11 2020	BUY Exercise of conversion of derivative security	$137,600 $13.85 p/Share	9,935 Added 15.7%	53,339 Common Stock

DOW

David O. Watson

General Counsel

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APLS shares.

Notify only if

Value

Insider Trading

Get notified when an Apellis Pharmaceuticals, Inc. insider buys or sells APLS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Apellis Pharmaceuticals, Inc.

Track Activities on APLS

Account